InsidersTradesSigma
Follow the 셀리드 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 셀리드 has recorded 4 public disclosures. Market capitalisation: €51.3bn. The latest transaction was reported on 6 May 2026 (Purchase). Among the most active insiders: 강창율. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
셀리드 operates in the health and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative solutions in the healthcare field.